Chronic Treatment with 17-DMAG Improves Balance and Coordination in A New Mouse Model of Machado-Joseph Disease-Reference-Cited by-同舟云学术

Chronic Treatment with 17-DMAG Improves Balance and Coordination in A New Mouse Model of Machado-Joseph Disease

Published:2014-01-30 Issue:2 Volume:11 Page:433-449
ISSN:1933-7213
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Silva-Fernandes Anabela,Duarte-Silva Sara,Neves-Carvalho Andreia,Amorim Marina,Soares-Cunha Carina,Oliveira Pedro,Thirstrup Kenneth,Teixeira-Castro Andreia,Maciel Patrícia

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s13311-013-0255-9.pdf

Reference53 articles.

1. Maciel P, Costa MC, Ferro A, Rousseau M, Santos CS, Gaspar C et al. Improvement in the molecular diagnosis of Machado-Joseph disease. Arch Neurol. 2001;58(11):1821–7.

2. Coutinho P, Andrade C. Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology. 1978;28(7):703–9.

3. Seidel K, den Dunnen WF, Schultz C, Paulson H, Frank S, de Vos RA et al. Axonal inclusions in spinocerebellar ataxia type 3. Acta Neuropathol. 2010;120(4):449–60.

4. Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997;19(2):333–44.

5. Huang S, Ling JJ, Yang S, Li XJ, Li S. Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor. Brain. 2011;134(Pt 7):1943–58.

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight into the early pathogenesis and therapeutic strategies of spinocerebellar ataxia type 3/machado–joseph disease from mouse models;Parkinsonism & Related Disorders;2024-09

2. The Role of Protein Quantity Control in Polyglutamine Spinocerebellar Ataxias;The Cerebellum;2024-07-25

3. Polyglutamine disorders: Pathogenesis and potential drug interventions;Life Sciences;2024-05

4. Spermidine treatment: induction of autophagy but also apoptosis?;Molecular Brain;2024-03-05

5. Glucocorticoid receptor-dependent therapeutic efficacy of tauroursodeoxycholic acid in preclinical models of spinocerebellar ataxia type 3;Journal of Clinical Investigation;2024-03-01